Abstract:Background Coronary microvascular dysfunction is common in patients of myocardial infarction with non‐obstructive coronary artery disease. Coronary flow reserve (CFR) reflects coronary microvascular function and is a powerful independent index of coronary microvascular dysfunction and heart failure. Our previous studies showed that knockout of SIRT3 (Sirtuin 3) decreased CFR and caused a diastolic dysfunction. Few studies focus on the treatment of impaired CFR and heart failure. In the present study, we explored the role of C646, a histone acetyltransferase p300 inhibitor, in regulating CFR and cardiac remodeling in SIRT3 knockout (SIRT3KO) mice. Methods and Results After treating with C646 for 14 days, CFR, pulse‐wave velocity, and cardiac function were measured in SIRT3KO mice. SIRT3KO mice treated with C646 showed a significant improvement of CFR, pulse‐wave velocity, ejection fraction, and fractional shortening. Treatment with C646 reversed pre‐existing cardiac fibrosis, hypertrophy, and capillary rarefaction in SIRT3KO mice. Mechanistically, knockout of Sirtuin 3 resulted in significant increases in p300 expression and H3K56 acetylation. Treatment with C646 significantly reduced levels of p300 and H3K56 acetylation in SIRT3KO mice. Furthermore, treatment with C646 increased endothelial nitric oxide synthase expression and reduced arginase II expression and activity. The expression of NF‐κB (nuclear factor kappa‐light‐chain‐enhancer of activated B cells) and VCAM‐1 (vascular cell adhesion molecule 1) was also significantly suppressed by C646 treatment in SIRT3KO mice. Conclusions C646 treatment attenuated p300 and H3K56 acetylation and improved arterial stiffness and CFR via improvement of endothelial cell (EC) dysfunction and suppression of NF‐κB. Nonstandard Abbreviations and Acronyms CFR coronary flow reserve CMD coronary microvascular dysfunction ECs endothelial cells eNOS endothelial nitric oxide synthase HAT histone acetyltransferase PWV pulse‐wave velocity ROS reactive oxygen species Clinical Perspective What Is New? SIRT3 (Sirtuin 3) was resident in the nuclei and knockout of SIRT3‐increased p300 and H3K56 acetylation. Treatment with a histone acetyltransferase p300 inhibitor (C646) attenuated p300 and H3K56 acetylation and revised the pre‐existing impairments of coronary flow reserve and cardiac function in SIRT3 knockout mice. C646 may alleviate coronary microvascular dysfunction via rebalancing arginase/endothelial nitric oxide synthase and attenuate cardiac remodeling via suppressing TLR‐4/IRAK‐4/MyD88–mediated NF‐κB. What Are the Clinical Implications? The prevalence of coronary microvascular dysfunction in myocardial infarction with nonobstructive coronary artery disease, defined as a reduced coronary flow reserve, is increasing at an alarming rate, and so far there is no proven treatments for coronary microvascular dysfunction because of the incomplete understanding of the underlying mechanisms. Our present study provides a novel role of the histone acetyltransferase p300 inhibitor on coronary microvascular dysfunction and cardiac remodeling and will create a new platform for drug discovery for the nonobstructive coronary artery disease in aged populations. Coronary artery disease is the leading cause of death in the United States and in developed countries. In patients of myocardial infarction with nonobstructive coronary artery disease, coronary microvascular dysfunction (CMD) is common as evidenced by a reduction in coronary flow reserve (CFR). CFR is the ratio of peak blood flow to basal blood flow, indicating the structural and functional conditions of coronary microcirculation. CFR is an essential predictor of cardiovascular diseases such as diastolic dysfunction and heart failure with preserved ejection fraction. 1 , <a class="tab-link" href="#jah35489-bib-00 -Abstract Truncated-

P53 Acetylation Exerts Critical Roles In Pressure Overload Induced Coronary Microvascular Dysfunction and Heart Failure

p53 Acetylation Exerts Critical Roles in Pressure Overload–Induced Coronary Microvascular Dysfunction and Heart Failure in Mice

Acetylation of mouse p53 at lysine 317 negatively regulates p53 apoptotic activities after DNA damage.

P53-Induced Inhibition of Hif-1 Causes Cardiac Dysfunction During Pressure Overload

Endothelial S1pr1 Regulates Pressure Overload‐induced Cardiac Remodelling Through AKT‐eNOS Pathway

Mouse SIRT3 Attenuates Hypertrophy-Related Lipid Accumulation in the Heart Through the Deacetylation of LCAD.

Histone Acetyltransferase p300 Inhibitor Improves Coronary Flow Reserve in SIRT3 (Sirtuin 3) Knockout Mice.

Acetylation of P53 Protein at Lysine 120 Up-regulates Apaf-1 Protein and Sensitizes the Mitochondrial Apoptotic Pathway*

Mitochondrial protein hyperacetylation underpins heart failure with preserved ejection fraction in mice

P53‐dependent Mitochondrial Compensation in Heart Failure with Preserved Ejection Fraction

SIRT3 Deficiency Enhances Ferroptosis and Promotes Cardiac Fibrosis via p53 Acetylation

Abstract 9553: Sirtuin1 Aggravates Hypertrophic Heart Failure Caused by Pressure Overload Via Shifting Energy Metabolism

Regulation of Acetylation Restores Proteolytic Function of Diseased Myocardium in Mouse and Human

Mitochondrial Fission is Required for Angiotensin II-Induced Cardiomyocyte Apoptosis Mediated by a Sirt1-p53 Signaling Pathway

Functional Investigations of p53 Acetylation Enabled by Heterobifunctional Molecules

Dynamics of the p53 acetylation pathway.

Acetylation Is Crucial for p53-Mediated Ferroptosis and Tumor Suppression

Autophagy modulates mesenchymal-to-endothelial transition via p53

Kielin/chordin‐like Protein Deficiency Aggravates Pressure Overload‐induced Cardiac Dysfunction and Remodeling Via P53/P21/CCNB1 Signaling in Mice

SRT2104 Attenuates Diabetes-Induced Aortic Endothelial Dysfunction Via Inhibition of P53.

Rg3 Regulates Myocardial Pyruvate Metabolism Via P300-mediated Dihydrolipoamide Dehydrogenase 2-Hydroxyisobutyrylation in TAC-induced Cardiac Hypertrophy